Phio Pharmaceuticals Statistics
Total Valuation
PHIO has a market cap or net worth of $2.05 million. The enterprise value is -$3.34 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, after market close.
Earnings Date | Nov 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
PHIO has 860,721 shares outstanding. The number of shares has increased by 227.50% in one year.
Current Share Class | 860,721 |
Shares Outstanding | 860,721 |
Shares Change (YoY) | +227.50% |
Shares Change (QoQ) | +94.05% |
Owned by Insiders (%) | 0.45% |
Owned by Institutions (%) | 3.31% |
Float | 856,852 |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 0.11 |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.48 |
P/TBV Ratio | 0.41 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.38
Current Ratio | 6.38 |
Quick Ratio | 5.87 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -122.03% and return on invested capital (ROIC) is -75.72%.
Return on Equity (ROE) | -122.03% |
Return on Assets (ROA) | -60.11% |
Return on Capital (ROIC) | -75.72% |
Revenue Per Employee | n/a |
Profits Per Employee | -$824,333 |
Employee Count | 9 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Dividends & Yields
PHIO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -227.50% |
Shareholder Yield | -227.50% |
Earnings Yield | -362.16% |
FCF Yield | -395.95% |
Analyst Forecast
The average price target for PHIO is $36.00, which is 1,412.61% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $36.00 |
Price Target Difference | 1,412.61% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on July 5, 2024. It was a reverse split with a ratio of 0.1111111:1.
Last Split Date | Jul 5, 2024 |
Split Type | Reverse |
Split Ratio | 0.1111111:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |